Summary:

Autophagy is an adaptive response to metabolic and therapeutic stress, especially in treatment-refractory cancers such as pancreatic cancer. In this issue of Cancer Discovery, two groups establish ferritinophagy, a selective autophagy program that could become a drug target, as the mechanism that pumps iron into mitochondria via the lysosome, enabling survival and therapy resistance in pancreas cancer.

See related article by Santana-Codina et al., p. 2180 (3).

See related article by Ravichandran et al., p. 2198 (4).

You do not currently have access to this content.